MSB 0.91% $1.11 mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-348

  1. 554 Posts.
    lightbulb Created with Sketch. 59
    and now it is being back up by long term survival data. You know what? Could it be that the drug is working?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.